Search Results - "Oevermann, Lena"
-
1
Lower incidence of grade II-IV acute Graft-versus-Host-Disease in pediatric patients recovering with high Vδ2+ T cells after allogeneic stem cell transplantation with unmanipulated bone marrow grafts: a prospective single-center cohort study
Published in Frontiers in immunology (29-07-2024)“…Gamma delta (γδ) T cells represent a minor fraction of human T cell repertoire but play an important role in mediating anti-infectious and anti-tumorous…”
Get full text
Journal Article -
2
-
3
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
Published in Haematologica (Roma) (01-07-2022)“…The course of sickle cell disease (SCD) is modified by polymorphisms boosting fetal hemoglobin (HbF) synthesis. However, it has remained an open question how…”
Get full text
Journal Article -
4
Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA‐DPB1 typing
Published in Pediatric blood & cancer (01-03-2020)“…Background New strategies to optimize donor selection for hematopoietic stem cell transplantation (HSCT) have mainly been evaluated in adults, but the disease…”
Get full text
Journal Article -
5
Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4 + CAR T Cell Efficacy
Published in Frontiers in immunology (31-03-2020)“…Chimeric antigen receptor (CAR) T cell efficacy against solid tumors is currently limited by several immune escape mechanisms, which may include tumor-derived…”
Get full text
Journal Article -
6
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL
Published in Bone marrow transplantation (Basingstoke) (01-11-2019)“…Although allogeneic hematopoietic stem-cell transplantation (HSCT) provides high cure rates for children with high-risk acute lymphoblastic leukaemia (ALL),…”
Get full text
Journal Article -
7
-
8
Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany-A Brief Narrative Review
Published in International journal of neonatal screening (28-01-2021)“…Sickle cell disease (SCD) is a severe non-malignant disorder of hemoglobin and is inherited in an autosomal-recessive manner [...]…”
Get full text
Journal Article -
9
Both mature KIR+ and immature KIR− NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice
Published in Blood (18-12-2014)“…Therapeutic natural killer (NK)-cell–mediated alloreactivity toward acute myeloid leukemia has largely been attributed to mismatches between killer…”
Get full text
Journal Article -
10
New strategies for haploidentical transplantation
Published in Pediatric research (01-04-2012)“…Haploidentical transplantation in children opens the possibility to offer this treatment to every child with an otherwise incurable disease, such as some…”
Get full text
Journal Article -
11
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
Published in Blood (23-10-2014)“…We analyzed the influence of donor killer-cell immunoglobulin-like receptor (KIR) gene haplotypes on the risk for relapse and the probability of event-free…”
Get full text
Journal Article -
12
Establishing Standard of Care in Predicting Serious Complications for Patients Planned to Undergo Allogenic Hematopeotic Stem Cell Transplantation
Published in Blood (02-11-2023)“…Background: There is no reliable way to predict the individual risk of suffering from relevant complications during the course of Hematopoetic Stem Cell…”
Get full text
Journal Article -
13
Artificial Intelligence (AI) Based, Machine Learning (ML) Predicting the Individual Absolute Risk of Acute Graft Versus Host Disease (aGvHD) in a Retrospective International Cohort
Published in Blood (02-11-2023)“…Background: HSCT still holds potentially lethal complications such as aGvHD, relapse of malignant disease, graft rejection, and infections. 30 to 50% of all…”
Get full text
Journal Article -
14
Real‐Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT‐HU cohort study
Published in American journal of hematology (01-10-2021)“…Several controlled studies have evidenced good efficacy and short‐term and mid‐term safety profiles for hydroxyurea (HU), which has become the cornerstone for…”
Get full text
Journal Article -
15
-
16
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma
Published in Clinical cancer research (02-05-2022)“…Treating refractory or relapsed neuroblastoma remains challenging. Monitoring body fluids for tumor-derived molecular information indicating minimal residual…”
Get full text
Journal Article -
17
HLA-haploidentical hematopoietic stem cell transplantation in pediatric patients with hemoglobinopathies: current practice and new approaches
Published in Bone marrow transplantation (Basingstoke) (01-08-2019)“…We review current approaches in HLA-haploidentical hematopoietic stem cell transplantation (haplo-HSCT) for pediatric patients with hemoglobinopathies with a…”
Get full text
Journal Article -
18
Benefits of a Disease Management Program for SCD in Germany 2011 - 2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome
Published in Blood (23-11-2021)“…Background Worldwide, Sickle Cell Disease (SCD) is the most common single gene disorder affecting >250,000 newborns annually. In Germany, SCD qualifies as a…”
Get full text
Journal Article -
19
Implementation of Escort-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study : Interests and Methodology
Published in Blood (23-11-2021)“…The efficacy and long-term effectiveness of hydroxycarbamide/hydroxyurea (HU) in the prevention of painful crises and in the decrease of mortality and…”
Get full text
Journal Article -
20
Single-cell multi-omics of mitochondrial DNA disorders reveals dynamics of purifying selection across human immune cells
Published in Nature genetics (01-07-2023)“…Pathogenic mutations in mitochondrial DNA (mtDNA) compromise cellular metabolism, contributing to cellular heterogeneity and disease. Diverse mutations are…”
Get full text
Journal Article